Fibrin(ogen)olytic and antiplatelet activities of a subtilisin-like protease from Solanum tuberosum (StSBTc-3)

cic.isFulltexttruees
cic.isPeerReviewedtruees
cic.lugarDesarrolloUniversidad Nacional de Mar del Plata es
cic.versioninfo:eu-repo/semantics/submittedVersiones
dc.date.accessioned2017-03-15T14:24:44Z
dc.date.available2017-03-15T14:24:44Z
dc.identifier.urihttps://digital.cic.gba.gob.ar/handle/11746/5342
dc.titleFibrin(ogen)olytic and antiplatelet activities of a subtilisin-like protease from Solanum tuberosum (StSBTc-3)en
dc.typeArtículoes
dcterms.abstractPlant serine proteases have been widely used in food science and technology as well as in medicine. In this sense, several plant serine proteases have been proposed as potential anti-coagulants and antiplatelet agents. Previously, we have reported the purification and identification of a plant serine protease from Solanum tuberosum leaves. This potato enzyme, named as StSBTc-3, has a molecular weight of 72 kDa and it was characterized as a subtilisin like protease. In this work we determine and characterize the biochemical and medicinal properties of StSBTc-3. Results obtained show that, like the reported to other plant serine proteases, StSBTc-3 is able to degrade all chains of human fibrinogen and to produces fibrin clot lysis in a dose dependent manner. The enzyme efficiently hydrolyzes b subunit followed by partially hydrolyzed a and g subunits of human fibrinogen. Assays performed to determine StSBTc-3 substrate specificity using oxidized insulin b-chain as substrate, show seven cleavage sites: Asn3-Gln4; Cys7-Gly8; Glu13-Ala14; Leu15-Tyr16; Tyr16-Leu17; Arg22-Gly23 and Phe25-Tyr26, all of them were previously reported for other serine proteases with fibrinogenolytic activity. The maximum StSBTc-3 fibrinogenolytic activity was determined at pH 8.0 and at 37 C. Additionally, we demonstrate that StSBTc- 3 is able to inhibit platelet aggregation and is unable to exert cytotoxic activity on human erythrocytes in vitro at all concentrations assayed. These results suggest that StSBTc-3 could be evaluated as a new agent to be used in the treatment of thromboembolic disorders such as strokes, pulmonary embolism and deep vein thrombosis.en
dcterms.creator.authorPepe, Alfonsoes
dcterms.creator.authorFrey, María Eugeniaes
dcterms.creator.authorMuñoz, Fernandoes
dcterms.creator.authorFernández, María Belénes
dcterms.creator.authorPedraza, Anabelaes
dcterms.creator.authorGalbán, Gustavoes
dcterms.creator.authorGarcía, Diana Noemíes
dcterms.creator.authorDaleo, Gustavo Raúles
dcterms.creator.authorGuevara, María Gabrielaes
dcterms.extent8 p.es
dcterms.isPartOf.issuevol. 125es
dcterms.isPartOf.seriesBiochimiees
dcterms.issued2016-03-24
dcterms.languageIngléses
dcterms.licenseAttribution-NonCommercial-NoDerivatives 4.0 International (BY-NC-ND 4.0)es
dcterms.subjectPlant serine proteasesen
dcterms.subjectAnticoagulant and antithrombotic agentsen
dcterms.subjectPlateletsen
dcterms.subject.materiaBiología Celular, Microbiologíaes

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Daleo - Fibrin.pdf-PDFA.pdf
Tamaño:
926.07 KB
Formato:
Adobe Portable Document Format
Descripción:
Documento completo